These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 30946232)
1. Intraoperative Peritoneal Washing Cytology on Survival in Pancreatic Ductal Adenocarcinoma With Resectable, Locally Advanced, and Metastatic Disease. Yin Z; Ma T; Chen S Pancreas; 2019 Apr; 48(4):519-525. PubMed ID: 30946232 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of intraoperative peritoneal washing cytology for patients with potentially resectable pancreatic ductal adenocarcinoma. Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Hoshi N; Hoshi S; Hirabayashi K; Ogata Y Pancreatology; 2017; 17(1):109-114. PubMed ID: 27840175 [TBL] [Abstract][Full Text] [Related]
3. Implications of peritoneal lavage cytology in resectable left-sided pancreatic cancer. Iwagami Y; Eguchi H; Wada H; Tomimaru Y; Hama N; Kawamoto K; Kobayashi S; Mori M; Doki Y; Nagano H Surg Today; 2015 Apr; 45(4):444-50. PubMed ID: 24975140 [TBL] [Abstract][Full Text] [Related]
4. Clinical importance of intraoperative peritoneal cytology in patients with pancreatic cancer. Abe T; Ohuchida K; Endo S; Ookubo F; Mori Y; Nakata K; Miyasaka Y; Manabe T; Ohtsuka T; Nagai E; Oda Y; Nakamura M Surgery; 2017 Apr; 161(4):951-958. PubMed ID: 27939334 [TBL] [Abstract][Full Text] [Related]
5. Prognostic importance of peritoneal washing cytology in patients with otherwise resectable pancreatic ductal adenocarcinoma who underwent pancreatectomy: A nationwide, cancer registry-based study from the Japan Pancreas Society. Tsuchida H; Fujii T; Mizuma M; Satoi S; Igarashi H; Eguchi H; Kuroki T; Shimizu Y; Tani M; Tanno S; Tsuji Y; Hirooka Y; Masamune A; Mizumoto K; Itoi T; Egawa S; Kodama Y; Hamada S; Unno M; Yamaue H; Okazaki K; Surgery; 2019 Dec; 166(6):997-1003. PubMed ID: 31445763 [TBL] [Abstract][Full Text] [Related]
6. Reappraisal of Total Pancreatectomy in 45 Patients With Pancreatic Ductal Adenocarcinoma in the Modern Era Using Matched-Pairs Analysis: Multicenter Study Group of Pancreatobiliary Surgery in Japan. Satoi S; Murakami Y; Motoi F; Sho M; Matsumoto I; Uemura K; Kawai M; Kurata M; Yanagimoto H; Yamamoto T; Mizuma M; Unno M; Kinoshita S; Akahori T; Shinzeki M; Fukumoto T; Hashimoto Y; Hirono S; Yamaue H; Honda G; Kwon M Pancreas; 2016 Aug; 45(7):1003-9. PubMed ID: 26692442 [TBL] [Abstract][Full Text] [Related]
8. Peritoneal washing cytology status as a crucial prognostic determinant in patients with localized pancreatic ductal adenocarcinoma who underwent curative-intent resection following preoperative chemoradiotherapy. Yuge T; Murata Y; Noguchi D; Ito T; Hayasaki A; Iizawa Y; Fujii T; Tanemura A; Kuriyama N; Kishiwada M; Mizuno S PLoS One; 2024; 19(9):e0309834. PubMed ID: 39240836 [TBL] [Abstract][Full Text] [Related]
9. Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or borderline resectable pancreatic ductal adenocarcinoma. Maruo M; Ikeura T; Takaori A; Ikeda M; Nakamaru K; Ito T; Masuda M; Mitsuyama T; Nakayama S; Shimatani M; Takaoka M; Shibata N; Boku S; Yasuda T; Miyazaki H; Matsumura K; Yamaki S; Hashimoto D; Satoi S; Naganuma M Pancreatology; 2024 Aug; 24(5):787-795. PubMed ID: 38871559 [TBL] [Abstract][Full Text] [Related]
10. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma. Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588 [TBL] [Abstract][Full Text] [Related]
11. Clinical impact of high-quality testing for peritoneal lavage cytology in pancreatic cancer. Tanemura M; Furukawa K; Mikamori M; Asaoka T; Yasuoka H; Marukawa D; Urata Y; Yamada D; Kobayashi S; Eguchi H Sci Rep; 2024 May; 14(1):10199. PubMed ID: 38702437 [TBL] [Abstract][Full Text] [Related]
12. Positive peritoneal lavage cytology is a predictor of worse survival in locally advanced pancreatic cancer. Clark CJ; Traverso LW Am J Surg; 2010 May; 199(5):657-62. PubMed ID: 20466112 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the prognostic impact of pre- and post-operative CA19-9, SPan-1, and DUPAN-II levels in patients with pancreatic carcinoma. Kondo N; Murakami Y; Uemura K; Nakagawa N; Takahashi S; Ohge H; Sueda T Pancreatology; 2017; 17(1):95-102. PubMed ID: 27746094 [TBL] [Abstract][Full Text] [Related]
14. Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic ductal adenocarcinoma? -Multicenter surgical group study. Yamamoto T; Satoi S; Kawai M; Motoi F; Sho M; Uemura KI; Matsumoto I; Honda G; Okada KI; Akahori T; Toyama H; Kurata M; Yanagimoto H; Yamaue H; Unno M; Kon M; Murakami Y Pancreatology; 2018 Jan; 18(1):106-113. PubMed ID: 29153701 [TBL] [Abstract][Full Text] [Related]
15. Preceding Systemic Chemotherapy for Patients with Pancreatic Ductal Adenocarcinoma with Positive Peritoneal Cytology Provides Survival Benefit Compared with Up-Front Surgery. Ariake K; Mizuma M; Motoi F; Maeda S; Morikawa T; Ishida M; Ohtsuka H; Aoki S; Miura T; Takadate T; Nakagawa K; Kamei T; Unno M Ann Surg Oncol; 2021 Oct; 28(11):6246-6254. PubMed ID: 33611747 [TBL] [Abstract][Full Text] [Related]
16. Perioperative cancer cell dissemination detected with a real-time RT-PCR assay for EpCAM is not associated with worse prognosis in pancreatic ductal adenocarcinoma. Sergeant G; Roskams T; van Pelt J; Houtmeyers F; Aerts R; Topal B BMC Cancer; 2011 Jan; 11():47. PubMed ID: 21281486 [TBL] [Abstract][Full Text] [Related]
17. Prognostic and predictive value of a five-molecule panel in resected pancreatic ductal adenocarcinoma: A multicentre study. Guo JC; Zhang P; Zhou L; You L; Liu QF; Zhang ZG; Sun B; Liang ZY; Lu J; Yuan D; Tan AD; Sun J; Liao Q; Dai MH; Xiao GG; Li S; Zhang TP EBioMedicine; 2020 May; 55():102767. PubMed ID: 32361251 [TBL] [Abstract][Full Text] [Related]
18. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability. Shi HJ; Jin C; Fu DL World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110 [TBL] [Abstract][Full Text] [Related]
19. The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer and its Prognostic Value Depends on Bilirubin Levels: A Retrospective Multicenter Cohort Study. Aziz MH; Sideras K; Aziz NA; Mauff K; Haen R; Roos D; Saida L; Suker M; van der Harst E; Mieog JS; Bonsing BA; Klaver Y; Koerkamp BG; van Eijck CH Ann Surg; 2019 Jul; 270(1):139-146. PubMed ID: 29334554 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Peritoneal Lavage Cytology in Patients with Pancreatic Ductal Adenocarcinoma Stratified by the Resectability Status. Sakoda T; Uemura K; Kondo N; Sumiyoshi T; Okada K; Seo S; Otsuka H; Murakami Y; Takahashi S J Gastrointest Surg; 2021 Nov; 25(11):2871-2880. PubMed ID: 33768425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]